Literature DB >> 14709661

Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma.

Nils G Morgenthaler1, Joachim Struck, Barbara Thomas, Andreas Bergmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14709661     DOI： 10.1373/clinchem.2003.021204

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  80 in total

1.  Higher plasma levels of MR-pro-atrial natriuretic peptide are linked to less anxiety: results from the observational DIAST-CHF study.

Authors:  Thomas Meyer; Christoph Herrrmann-Lingen; Mira-Lynn Chavanon; Kathleen Nolte; Caroline Anna Pasedach; Lutz Binder; Burkert Pieske; Gerd Hasenfuss; Rolf Wachter; Frank Edelmann
Journal:  Clin Res Cardiol       Date:  2015-02-10       Impact factor: 5.460

2.  Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy.

Authors:  Elif Elmas; Christina Doesch; Stephan Fluechter; Miriam Freundt; Christel Weiss; Siegfried Lang; Thorsten Kälsch; Dariush Haghi; Jana Papassotiriou; Jan Kunde; Stefan O Schoenberg; Martin Borggrefe; Theano Papavassiliu
Journal:  Int J Cardiovasc Imaging       Date:  2010-09-26       Impact factor: 2.357

Review 3.  Natriuretic peptides in cardiovascular diseases: current use and perspectives.

Authors:  Massimo Volpe; Speranza Rubattu; John Burnett
Journal:  Eur Heart J       Date:  2013-11-13       Impact factor: 29.983

Review 4.  Biomarkers for risk prediction in acute decompensated heart failure.

Authors:  A Rogier van der Velde; Wouter C Meijers; Rudolf A de Boer
Journal:  Curr Heart Fail Rep       Date:  2014-09

5.  Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.

Authors:  Olle Melander; Christopher Newton-Cheh; Peter Almgren; Bo Hedblad; Göran Berglund; Gunnar Engström; Margaretha Persson; J Gustav Smith; Martin Magnusson; Anders Christensson; Joachim Struck; Nils G Morgenthaler; Andreas Bergmann; Michael J Pencina; Thomas J Wang
Journal:  JAMA       Date:  2009-07-01       Impact factor: 56.272

6.  Procalcitonin and Midregional Proatrial Natriuretic Peptide as Markers of Ischemic Stroke: The Northern Manhattan Study.

Authors:  Mira Katan; Yeseon P Moon; Myunghee C Paik; Beat Mueller; Andreas Huber; Ralph L Sacco; Mitchell S V Elkind
Journal:  Stroke       Date:  2016-05-19       Impact factor: 7.914

7.  Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertension.

Authors:  Mahyar Khaleghi; Umer Saleem; Nils G Morgenthaler; Stephen T Turner; Andreas Bergmann; Joachim Struck; Thomas H Mosley; Iftikhar J Kullo
Journal:  Am J Hypertens       Date:  2009-02-12       Impact factor: 2.689

8.  Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study.

Authors:  Charles X Kim; Kent R Bailey; George G Klee; Allison A Ellington; Guanghui Liu; Thomas H Mosley; Hamid Rehman; Iftikhar J Kullo
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

Review 9.  Biomarkers in acute myocardial infarction.

Authors:  Daniel Chan; Leong L Ng
Journal:  BMC Med       Date:  2010-06-07       Impact factor: 8.775

10.  Endothelial markers may link kidney function to cardiovascular events in type 2 diabetes.

Authors:  Christina Maier; Martin Clodi; Stephanie Neuhold; Michael Resl; Marie Elhenicky; Rudolf Prager; Deddo Moertl; Guido Strunk; Anton Luger; Joachim Struck; Richard Pacher; Martin Hülsmann
Journal:  Diabetes Care       Date:  2009-06-29       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.